To assess the capability of TIINDRR to report tumor–immune interactions in diverse tissues, we adoptively transferred antigen-specific P14 CD8+ T cell receivers systemically into Rag2−/− mice with established YMR-mGFP metastases expressing the LCMV GP antigen (YMRGP) (Fig. 2D). Here, CD8A is linked to neoplasm.